Scientific Program
GP1 - EVER Society - Controversies in the diagnosis and treatment of retinal disorders in three continents
Date
13/03/2026
Hall
Atlantiis 2
From
15:15
To
16:25
Summary
1. Maciej Gawęcki (Dobry Wzrok Ophthalmological Center , Gdansk, Poland) - Current Recommendactions for the treatment of central serous chorioretinopathy 2. Adrain Smędowski - (Medical University of Silesia, Katowice, Poland) - FAS pathway modulators and serotonin reuptake inhibitors - the new applications of known drugs in ischemic retinal diseases 3. Vivek Dave - Dual Inhibition in AMD - how does it help? 4. Ali Erginayi - (Ophthalmology Department, Lariboisière Hospital, Paris, France) - UWF -OCTA in diagnostics of retinal diseases. Up-date 5. Lyubomir Lytvynchuk (University of Giesen, Germany) - Subretinal hemorrhages: conventional and novel treatment approaches
Membership No
Name
Topic
Role
Duration
Consented
Non Member
Dr.Maciej Gawecki
Current Recommendactions for the treatment of central serous chorioretinopathy
Speaker
Yes
Non Member
Dr.Adrain Smedowski
FAS pathway modulators and serotonin reuptake inhibitors - the new applications of known drugs in ischemic retinal diseases
Speaker
Yes
D12385
Dr.Vivek Dave
Dual Inhibition in AMD - how does it help?
Speaker
Yes
Non Member
Dr.Ali Erginay
UWF -OCTA in diagnostics of retinal diseases. Up-date
Speaker
Yes
Non Member
Dr.Lyubomir Lytvynchuk
Subretinal hemorrhages: conventional and novel treatment approaches
Speaker
